Results 221 to 230 of about 60,441 (347)

Sample size requirements to evaluate policies in addiction research using interrupted time series analysis (ITS): Tools and guidance

Addiction, EarlyView.
Abstract Formal power calculations are rarely presented in interrupted time‐series (ITS) studies due to their technical complexity, creating a significant gap in methodological rigor. This paper aimed to make power and sample size determination more accessible for researchers, particularly in the field of addiction, by providing a suite of practical ...
Emma Beard, Jamie Brown, Lion Shahab
wiley   +1 more source

Contingency management interventions for substance use and addictive behaviours: Review of the United Kingdom evidence base

Addiction, EarlyView.
Abstract Background and aims Substance use and other addictive behaviours including gambling remain major public health concerns in the UK. Despite the effectiveness of substance use treatment approaches, treatment adherence and success rates remain low.
Carol‐Ann Getty, Tricia McQuarrie, Eileen Brobbin   +2 more
wiley   +1 more source

Pre-exposure prophylaxis (PrEP) and medications for opioid use disorder for persons who inject drugs: the CHORUS + randomized controlled trial study protocol. [PDF]

Addict Sci Clin Pract
Miller SE, Dukes KA, Damato-MacPherson C, Psaros C, Scott NA, Taylor JL, Muroff J, Winter MR, Skiba LE, Lugo H, Cruz R, Ruiz-Mercado G, Crawford ND, Mayer KH, Assoumou SA.   +14 more
europepmc   +1 more source

Drug use among people in prison: A global review of epidemiology, harms and interventions

Addiction, EarlyView.
Abstract Background and aims People who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.
Louis Favril, John Strang, Seena Fazel
wiley   +1 more source

Characterizing the Association Between Traumatic Brain Injury and Discontinuation of Medications for Opioid Use Disorder in a Commercially Insured Adult Population [PDF]

Jake R. Morgan, Sharon Reif, Maureen T. Stewart, Marc R. Larochelle, Rachel Sayko Adams   +4 more
openalex   +1 more source

Payment-Related Barriers to Medications for Opioid Use Disorder: A Critical Review of the Literature and Real-World Application

, 2023
Diana Bowser, Robert Bohler, Margot T. Davis, Dominic Hodgkin, Constance M. Horgan   +4 more
openalex   +1 more source

Exploring the genetic overlap between substance use disorder and educational attainment

Addiction, EarlyView.
Abstract Background and aims Substance use disorder (SUD) is a polygenic psychiatric condition characterized by persistent drug use despite negative consequences. Several studies support that higher cognitive performance and educational attainment (EA) are associated with a reduced risk for SUD.
Judit Cabana‐Domínguez, Laura Vilar‐Ribó, María Soler Artigas, Silvia Alemany, Natalia Llonga, Pau Carabí‐Gassol, Uxue Zubizarreta‐Arruti, Valeria Macias‐Chimborazo, Lara Grau‐López, Constanza Daigre, Elena Ros‐Cucurull, Raúl Felipe Palma‐Alvarez, Germán Ortega‐Hernández, Noèlia Fernàndez‐Castillo, Bru Cormand, Josep Antoni Ramos‐Quiroga, Marta Ribasés   +16 more
wiley   +1 more source

Using narrative and informational messages to improve correctional professionals' attitudes toward medications for opioid use disorder. [PDF]

Health Justice
Harrell-Webber A, Zhao X, Horoszko UA, Murphy A, Smith L, Taxman FS.   +5 more
europepmc   +1 more source

The Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care: A Cross-Sectional Survey and Brief Intervention

, 2022
Joanna Krupp, Frances Hung, Tina Tucker, Michael E Yarrington, Katherine Link, Yujung Choi, Hillary Chen, Andrea C. Des Marais, Nidhi Sachdeva, Hrishikesh Chakraborty, Mehri S. McKellar   +10 more
openalex   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source